Last Change % Change
SPY 236.81 -0.30 -0.13%
DIA 208.19 -0.10 -0.05%
IWM 138.905 -1.095 -0.782%
QQQ 130.27 -0.15 -0.12%

Prices may be delayed by 15 minutes or more.

Value investing


With $19.5 Million in Coffers from Asset Sale, Sonoma Pharmaceuticals Sets Sights on Breakeven

Wall Street is all about forward-looking valuations, but that doesn’t seem to be the case with Sonoma. In fact, investors are overlooking the obvious in that the company isn’t even valued fairly compared to the cash it has on hand. The sale amount was greater than the total market capitalization of Sonoma at the time of the news. It is foreseeable that as Sonoma continues to fulfill its promises, the market could correct to a forward-looking valuation.

U.S. Geothermal Wraps Up Record Year with Numerous Upcoming Catalysts

Hispanica (HISP): An Attractive Play in a Consolidating Industry

Hispanica Delights (HISP) Gains Momentum in Fiscal Q1

Hispanica International (HISP) is Growing Revenue and Increasing Transparency

Consolidation in Ethnic Foods Market Could Benefit Hispanica (HISP)